Page last updated: 2024-11-13

copper indium diselenide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID56841035
MeSH IDM0266736

Synonyms (2)

Synonym
copper indium diselenide
indium copper selenide (incuse2)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Based on changes in lung weight, BALF indices, and histopathology, CT was the most toxic for the lung; CIS had intermediate toxicity and CGS was the least toxic."( Acute pulmonary toxicity of copper gallium diselenide, copper indium diselenide, and cadmium telluride intratracheally instilled into rats.
Elwell, MP; Jeter, SP; Morgan, DL; Moskowitz, PD; Price, HC; Shines, CJ; Wilson, RE, 1995
)
0.54
" It was thought that indium compounds were not harmful until the beginning of the 1990s because there was little information regarding the adverse health effects on humans or animals arising from exposure to indium compounds."( [Health effects of solar cell component material. Toxicity of indium compounds to laboratory animals determined by intratracheal instillations].
Hirata, M; Tanaka, A, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (8.70)18.2507
2000's2 (8.70)29.6817
2010's19 (82.61)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.54 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index5.20 (4.65)
Search Engine Demand Index49.01 (26.88)
Search Engine Supply Index2.02 (0.95)

This Compound (37.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]